Annual public health and economic benefits of seasonal influenza vaccination: A European estimate

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Preaud, Emmanuelle ^a   Durand, Laure ^a   Macabeo, Bérengère ^a   Farkas, Norbert ^b   Sloesen, Brigitte ^c   Palache, Abraham ^d   Shupo, Francis ^e   Samson, Sandrine I ^a  

^a SANOFI PASTEUR   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

^c GSK   (Belgium)

^d GlaxoSmithKline ^*  (Netherlands)

^e CREATIV CEUTICAL   (France)

Author keywords

Epidemiology; Influenza; Modeling; Public health policy; Vaccines and immunization

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; CHILD; ECONOMICS; EUROPE; FEMALE; HUMAN; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREGNANCY; PUBLIC HEALTH; SEASON; VACCINATION; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; EUROPE; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREGNANCY; PUBLIC HEALTH; SEASONS; VACCINATION;

EID: 84908348840     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-813     Document Type: Article

References (57)

1. Vaccines against influenza WHO position paper-November 2012. World Health Organization, Wkly Epidemiol Rec 2012 47 461 476
2. Influenza seasonal. World Health Organization, [ http://www.who.int/mediacentre/factsheets/fs211/en/ ]
3. th Sept 2010 on: Revised estimates of deaths associated with seasonal influenza in the US. European Centers for Disease Prevention and Control: Stockholm, [ http://www.ecdc.europa.eu/en/activities/sciadvice/-layouts/forms/Review-DispForm.aspx?List=a3216f4c-f040-4f51-9f77-a96046dbfd72&ID=394 ]
4. Influenza-related mortality in Spain, 1999-2005. de MS Lopez-Cuadrado T, Jimenez-Jorge S, Savulescu C, Larrauri A, Gac Sanit 2012 26 325 329 10.1016/j.gaceta.2011.09.033 22284214
5. A study of excess mortality during influenza epidemics in the Czech Republic, 1982-2000. Kyncl J, Prochazka B, Goddard NL, Havlickova M, Castkova J, Otavova M, Kriz B, Eur J Epidemiol 2005 20 365 371 10.1007/s10654-005-1067-y 15971510
6. Seasonal flu-economic impact. European Scientific Working Group on Influenza, [ http://flucentre.net/knowledge-centre/seasonal-flu/economic-impact ]
7. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Ryan J, Zoellner Y, Gradl B, Palache B, Medema J, Vaccine 2006 24 6812 6822 17034909
8. Influenza season 2012-2013 is over in Europe. European Centers for Disease Prevention and Control: Stockholm, [ http://ecdc.europa.eu/en/press/news/-layouts/forms/News-DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568&ID=96 ]
9. Review of the 2012-2013winter influenza season, northern hemisphere. World Health Organization, Wkly Epidemiol Rec 2013 22 225 232
10. Bilan de la saison grippale 2012-2013. Groupe Regionaux d'Observation de la Grippe, 2013
11. Grippe: l'épidémie exceptionnelle va coûter cher à la Sécurité sociale. [ http://www.lesechos.fr/22/02/2013/LesEchos/21382-018-ECH-grippe - -l-epidemie-exceptionnelle-va-couter-cher-a-la-securite-sociale.htm
12. La grippe de cet hiver aura coute plus de 200 millions d'Euros. La grippe de cet hiver aura coute plus de 200 millions d'Euros, [ http://www.lesechos.fr/26/03/2013/lesechos.fr/0202666032156-la-grippe-de-cet-hiver-aura-coute-plus-de-200-millions-d-euros.htm
13. Proposal for a council recommendation on seasonal influenza vaccination. Commission of the European Communities, [ http://www.epha.org/IMG/pdf/seasonflu-rec2009-en.PDF
14. Inactivated influenza vaccines. Bridges CB, Katz JM, Levandowski RA, Cox NJ, Vaccines Philadelphia: Saunders Elsevier, Plotkin SA, Orenstein WA, Offit PA, 5 2008 259 290
15. Low effectiveness undermines promotion of seasonal influenza vaccine. Nicoll A, Sprenger M, Lancet Infect Dis 2013 13 7 9 10.1016/S1473-3099(12)70313-4 23257219
16. Council recommendation of 22 December 2009 on seasonal influenza vaccination. The Council of the European Union, [ http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF
17. Health at a Glance Europe. Organization for Economic Co-operation and Development, 2012 [ http://ec.europa.eu/health/reports/docs/health-glance-2012-en.PDF
18. Monitoring the implementation of the Council recommendation on seasonal influenza vaccination (2009/1019/EU). Noori T, [ http://ecdc.europa.eu/en/press/events/Documents/Monitoring-Council-Recommendation-Seasonal-Influenza-Vaccination.PDF
19. Vaccination coverage assessment in EU/EEA, 2011. VENICE II Consortium, [ http://venice.cineca.org/Final-Vaccination-Coverage-Assesment-Survey-2011-1.PDF
20. Final report seasonal influenza vaccination survey in EU/EEA, influenza season 2009-10. VENICE II Consortium, [ http://venice.cineca.org/Final-Seasonal-Influenza-Vaccination-Survey-2010.PDF
21. Final report national seasonal influenza vaccination survey in Europe. VENICE Research Team, 2007 [ http://www.google.ca/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=3&ved=0CD8QFjAC&url=http%3A%2F%2Fvenice.cineca.org%2FInfluenza-Study-Report-v1.0.pdf&ei=cj5vUp-nCerWyQHZg4DgCw&usg=AFQjCNEDFnojrPtelEe3cN8xLAqKOmpF6Q&bvm=bv.5512311 5,d.aWc ]
22. European community statistics. Eurostat, 2008 [ http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home ]
23. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Kroneman M, Van Essen GA, John PW, Vaccine 2006 24 622 628 16169638
24. National Seasonal Influenza Vaccination Survey in Europe, 2008. Mereckiene J, Cotter S, Nicoll A, Lévy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, Euro Surveill 2008 13 1 7
25. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Mereckiene J, Cotter S, Weber JT, Nicoll A, Lévy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, Euro Surveill 2008 13 2 4
26. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. Blank PR, Schwenkglenks M, Szucs TD, J Infect 2009 58 446 458 10.1016/j.jinf.2009.04.001 19446340
27. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Mereckiene J, Cotter S, D'Ancona F, Giambi C, Nicoll A, Levy-Bruhl D, Lopalco PL, Weber JT, Johansen K, Dematte L, Salmaso S, Stefanoff P, Greco D, Dorleans F, Polkowska A, O'Flanagan D, Euro Surveill 2010 15 11 20
28. Coberturas de Vacunación. Datos Estadisticos. Gobierno de Espana, Ministerio de Sanidad, Servicios Sociales, e Igualidad, 2010 [ http://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/coberturas.htm
29. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. Emborg HD, Krause TG, Hviid A, Simonsen J, Molbak K, BMJ 2012 344 7901
30. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Chang PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breece Hall C, Monto AS, Griffin MR, Belongia E, Shay DK, USFlu-VE, Network, Clin Infect Dis 2012 55 7 951 959 10.1093/cid/cis574 22843783
31. I-MOVE multicenter case control study 2010-2011: overall and stratified estimates of influenza vaccine effectiveness in Europe. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, Stefanoff P, Nunes B, Pitigoi D, Larrauri A, Daviaud I, Horvath JK, O'Donnell J, Seyler T, Paradowska-Stankiewicz IA, Pechirra P, Ivanciuc AE, Jimenez-Jorge S, Savulescu C, Ciancio BC, Moren A, PLoS One 2011 6 27622 10.1371/journal.pone.0027622 22110695
32. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in europe: results from the i-move multicentre case-control study. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitigoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jimenez-Jorge S, Horvath JK, Daviaud I, Guiomar R, Necula G, Bella A, O'Donnell J, Gluchowska M, Ciancio BC, Nicoll A, Moren A, Euro Surveill 2013 18 5 20390 23399425
33. Vaccines for preventing influenza in healthy children. Jefferson T, Rivetti A, Di PC, Demicheli V, Ferroni E, Cochrane Database Syst Rev 2012 8 D004879 22895945
34. Vaccines for preventing influenza in healthy adults. Jefferson T, Di PC, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E, Cochrane Database Syst Rev 2010 7 D001269 20614424
35. Vaccines for preventing influenza in the elderly. Jefferson T, Di PC, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE, Cochrane Database Syst Rev 2010 2 D004876 20166072
36. Assessing the burden of influenza and other respiratory infections in England and Wales. Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, Edmunds WJ, J Infect 2007 54 530 538 10.1016/j.jinf.2006.09.017 17097147
37. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E, Eur Respir J 2007 30 1158 1166 10.1183/09031936.00034407 17715167
38. Influenza associated excess mortality in Germany, 1985-2001. Zucs P, Buchholz U, Haas W, Uphoff H, Emerg Themes Epidemiol 2005 2 6 10.1186/1742-7622-2-6 15969758
39. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Rizzo C, Bella A, Viboud C, Simonsen L, Miller MA, Rota MC, Salmasao S, Ciofi degli Atti ML, Emerg Infect Dis 2007 13 5 694 699 10.3201/eid1305.061309 17553246
40. Surveillance of influenza and other respiratory viruses in the UK, 2010/2011. Health Protection Agency (UK), 2011
41. Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004. Gran JM, Iversen B, Hungnes O, Aalen OO, Epidemiol Infect 2010 138 1559 1568 10.1017/S0950268810000671 20334732
42. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Carrat F, Sahler C, Rogez S, Leruez-Ville M, Freymuth F, Le Gales C, Bungener M, Housset B, Nicolas M, Rouzioux C, Arch Intern Med 2002 162 1842 1848 10.1001/archinte.162.16.1842 12196082
43. Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study. Galante M, Garin O, Sicuri E, Cots F, Garcia-Altes A, Ferrer M, Dominguez A, Alonso J, PLoS One 2012 7 2 31696 10.1371/journal.pone.0031696 22348122
44. Choosing Interventions that are Cost Effective (WHO-CHOICE). World Health Organisation, [ http://www.who.int/choice/en/ ]
45. Tarifs des consultations du médecin traitant (applicables au 26 mars 2012). [ http://www.ameli.fr/assures/soins-et-remboursements/combien-serez-vous-rembourse/consultations/les-consultations-en-metropole/dans-le-cadre-du-parcours-de-soins-coordonnes.php
46. Use of Services and Costs of Patients With Flu (H1N1) 2009 In Spain: Background and Research Protocol (In Spanish). Garin O, Galante M, García-Altés A, Sicuri E, Cots F, Nebot M, Ferrer M, Dominguez A, Alonso J, Rev Esp Salud Publica 2011 85 19 31 21750839
47. OECD. StatExtracts. Organization for Economic Co-operation and Development, [ http://stats.oecd.org/ ]
48. Unit Costs of Health and Social Care 2011-PSSRU. Lesley Curtis, [ http://www.pssru.ac.uk/project-pages/unit-costs/2012/ ]
49. Costs of Treating Infections caused by breathing viruses and pneumonia in the elderly population in Poland (In Polish). Jahnz-Rozyk K, 2012
50. Implementing an influenza vaccination programme for adults aged >/=65 years in Poland: a cost-effectiveness analysis. Brydak L, Roiz J, Faivre P, Reygrobellet C, Clin Drug Investig 2012 32 73 85 10.2165/11594030-000000000-00000 22201294
51. Sweden health system review. Anell A, Glenngard AH, Merkur S, Health Syst Transit 2012 14 1 159
52. Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model. Pitman RJ, Nagy LD, Sculpher MJ, Vaccine 2013 31 6 927 942 10.1016/j.vaccine.2012.12.010 23246550
53. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ, Am J Prev Med 2006 31 72 79 10.1016/j.amepre.2006.03.008 16777545
54. Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. Kostova D, Reed C, Finelli L, Cheng P-Y, Gargiullo PM, Shay DK, Singleton JA, Meltzer MI, Lu P, Bresee JS, PLoS One 2013 8 6 66312 10.1371/journal.pone.0066312 23840439
55. The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Blank PR, Schwenkglenks M, Szucs T, Hum Vaccin Immunother 2012 8 328 335 10.4161/hv.18629 22327498
56. Vaccines Europe. Vaccines Europe, [ http://www.vaccineseurope.eu/ ]
57. Vaccines, Blood and Biologics-approved products. US Food and Drug Administration, [ http://www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/post-marketactivities/lotreleases/ucm397090.htm